Antibody Engineering and Therapeutics

11-15 December 2017

San Diego, CA, USA

Share this article:

John McCafferty CEO and founder of IONTAS will present on our proprietary mammalian display technology in a talk entitled "Antibody-display Libraries in Mammalian Cells Created Using CRISPR/Cas9 and TALE Nucleases". The presentation will outline the benefits of mammalian display in both selecting functional antibodies and obtaining early data on the likely developability of the selected antibodies.